Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

U.S. Plans Tariffs up to 100% on Some Brand-Name Drugs

TUESDAY, April 7, 2026 The United States is planning new tariffs on some name-brand medicines. The move could affect drug prices and how medicines are made. Off

This New Method May Make French Fries Lower in Fat

TUESDAY, April 7, 2026 Love French fries but not the extra fat Scientists say they may have found a way to make them healthier without losing their crunch. Rese

Wawa Recalls Drinks Over Undeclared Milk Allergen

TUESDAY, April 7, 2026 Several popular drinks sold at Wawa are being recalled because they may contain an undeclared milk allergen. The recall includes 16-ounce

Scientists Test New Ways To Regrow Joints Damaged by Arthritis

TUESDAY, April 7, 2026 Good news Scientists may be closer to a new way to treat arthritis. The Advanced Research Projects Agency for Health (ARPA-H) said severa

Variable Correlations Seen Between Geographic Atrophy Enlargement Rates in Fellow Eyes

The geographic atrophy (GA) enlargement rate in one eye does not consistently predict the enlargement rate in the fellow eye, according to a study published onl

Switching From HIV Protease Inhibitors to Integrase Strand Transfer Inhibitors Tied to Diabetes Risk

Switching to integrase strand transfer inhibitors (INSTI) from protease inhibitors is associated with new diabetes risk in people with HIV, according to a study

Low Food Access Associated With Adverse Outcomes After Mastectomy

Low food access (LFA) is associated with increased comorbidities and postoperative complications for women undergoing mastectomy, according to a study published

Women With DM Receive Less Recommended Preventive Care Than Those Without DM

Reproductive-aged women with diabetes mellitus (DM) receive recommended preventive health services at a lower rate than those without DM, according to a study p

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Context Therapeutics Inc. ( Context or the Company ) (Nasdaq CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging ( TCE ) bispecific anti

Popular Keywords